1-(3,4-二氯苯基)-吡咯-2,5-二酮 | 19844-27-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯啉
• 中文名称: 1-(3,4-二氯苯基)-吡咯-2,5-二酮
• 中文别名: 1-(3,4-二氯苯基)-1H-吡咯-2,5-二酮
• 英文名称: 1-(3,4-dichlorophenyl)pyrrole-2,5-dione
• 英文别名: N-3,4-dichlorophenylmaleimide；1-(3,4-dichlorophenyl)-1H-pyrrole-2,5-dione
• CAS: 19844-27-0
• 化学式: C₁₀H₅Cl₂NO₂
• mdl: MFCD00540221
• 分子量: 242.061
• InChiKey: PJBXBDSTURWRBO-UHFFFAOYSA-N

物化性质

• 熔点：
  170 °C
• 沸点：
  396.2±32.0 °C(Predicted)
• 密度：
  1.570±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  37.4
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2925190090

反应信息

• 作为反应物：
  描述：

  1-(3,4-二氯苯基)-吡咯-2,5-二酮 在 吡啶 、 氯化亚砜 作用下， 反应 1.25h， 以45%的产率得到3,4-二氯-1-(3,4-二氯苯基)吡咯-2,5-二酮
  参考文献：
  名称：

  An Optimized RAD51 Inhibitor That Disrupts Homologous Recombination without Requiring Michael Acceptor Reactivity

  摘要：

  Homologous recombination (HR) is an essential process in cells that provides repair of DNA double-strand breaks and lesions that block DNA replication. RAD51 is an evolutionarily conserved protein that is central to HR. Overexpression of RAD51 protein is common in cancer cells and represents a potential therapeutic target in oncology. We previously described a chemical inhibitor of RAD51, called RI-1 (referred to as compound 1 in this report). The chloromaleimide group of this compound is thought to act as a Michael acceptor and react with the thiol group on C319 of RAD51, using a conjugate addition-elimination mechanism. In order to reduce the likelihood of off-target effects and to improve compound stability in biological systems, we developed an analogue of compound 1 that lacks maleimide-based reactivity but retains RAD51 inhibitory activity. This compound, 1-(3,4-dichlorophenyl)-3-(4-methoxyphenyl)-4-morpholino-1H-pyrrole-2,5-dione, named RI-2 (referred to as compound 7a in this report), appears to bind reversibly to the same site on the RAD51 protein as does compound 1. Like compound 1, compound 7a specifically inhibits HR repair in human cells.

  DOI：

  10.1021/jm301565b
• 作为产物：
  描述：

  N-(3,4-二氯苯基)马来酸 在 sodium acetate 、 乙酸酐 作用下， 生成 1-(3,4-二氯苯基)-吡咯-2,5-二酮
  参考文献：
  名称：

  含有细胞毒性 1,4-dioxo-2-butenyl 药效团的芳胺衍生物

  摘要：

  已制备了若干系列含有 1,4-二氧-2-丁烯基部分的化合物作为候选细胞毒素，包括N-芳基马来酸甲酯、N-芳基富马酸甲酯和N-芳基马来酰亚胺。此外，合成了N-芳基异马来酰亚胺，它是N-芳基马来酰亚胺的结构异构体。这些化合物针对人 Molt 4/C8 和 CEM T 淋巴细胞以及鼠 L1210 细胞进行了评估。N-芳基富马酸甲酯显示出最高的细胞毒性效力，尤其是甲基N-(3,4-二氯苯基)富马酸盐对 L1210 细胞的作用是马法兰的六倍，在 Molt 4/C8 试验中与该药物等效。通过使用模型苄基硫醇对代表性化合物进行硫醇化来证明所研究化合物的亲电性。甲基ñ - （3,4-二氯苯基）fumaramate和甲基ñ - （4-氯苯基）马来酰胺酸抑制人Ñ -myristoyltransferase，可能的分子靶标，在高微摩尔范围。QSAR 和分子建模揭示了许多分子的不同结构特征与细胞毒性效力之间的一些

  DOI：

  10.1016/j.bmcl.2010.01.098

文献信息

• [EN] GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS DE GLYCOLATE OXYDASE POUR LE TRAITEMENT D'UNE MALADIE
  申请人：BIOMARIN PHARM INC

  公开号：WO2020257487A1

  公开（公告）日：2020-12-24

  Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

  本文描述了化合物、制备这种化合物的方法、含有这种化合物的药物组合物和药物，以及使用这种化合物治疗或预防与甘氧酸代谢缺陷相关的疾病或紊乱的方法，例如与甘氧酸氧化酶（GO）或草酸代谢变化相关的疾病或紊乱。这些疾病或紊乱包括与产生过多草酸相关的甘氧酸代谢紊乱，例如原发性高草酸尿症。
• Synthesis and Characterization of Exo‐endo and Endo‐endo Benzenesulfonylaziridines
  作者：Evilazio da Silva Andrade、Ricardo José Nunes、Marina Uieara

  DOI：10.1081/scc-200028524

  日期：2004.1

  Abstract In the search for structural cyclic imide analogues of therapeutic interest, the synthesis, separation, and characterization of exo‐endo 3 and endo‐endo 4 stereoisomers of benzenesulfonylaziridines, not found in the literature, are described in this study. The benzenesulfonylaziridines were synthesized through a 1,3‐dipolar‐type reaction of p‐toluenesulfonylazide and different norbornenesuccinimides

  摘要 在寻找具有治疗意义的结构环状酰亚胺类似物的过程中，本研究描述了文献中未发现的苯磺酰氮丙啶外型 3 和内型 4 立体异构体的合成、分离和表征。苯磺酰氮丙啶是通过对甲苯磺酰叠氮和不同降冰片烯琥珀酰亚胺的 1,3-偶极型反应合成的。
• Phase‐Transfer Catalytic Strategy: Rapid Synthesis of Spiro‐Fused Heterocycles, Integrated with Four Pharmacophores‐Succinimide, Pyrrolidine, Oxindole, and Trifluoromethyl Group
  作者：Zheng‐Jun Chen、Wei Liang、Zhuo Chen、Lin Chen

  DOI：10.1002/ejoc.202001409

  日期：2021.2.5

  A phase‐transfer catalytic 1,3‐dipolar [3+2] cycloaddition grants rapid generation of various trifluoromethyl spiro‐fused[succinimide‐pyrrolidine‐oxindole]s that might be of great utility for drug discovery. The gram‐scale reaction in conjunction with the derivatizations of the product demonstrate the synthetic potential of this methodology. The reaction mechanism is also discussed.

  相转移催化的1,3-偶极[3 + 2]环加成反应可快速生成各种三氟甲基螺旋稠合的[琥珀酰亚胺-吡咯烷-氧吲哚]，这些化合物可能对药物发现有很大的帮助。克级反应以及产物的衍生化证明了该方法的合成潜力。还讨论了反应机理。
• Ruthenium(II)-Catalyzed Hydroarylation of Maleimides Using Carboxylic Acids as a Traceless Directing Group
  作者：Anup Mandal、Harekrishna Sahoo、Suman Dana、Mahiuddin Baidya

  DOI：10.1021/acs.orglett.7b01964

  日期：2017.8.4

  ready-stock aryl carboxylic acids has been developed based on weak carboxylate-directed ortho-C–H alkylation and concomitant decarboxylation processes, fabricating 3-aryl succinimides, a recurrent scaffold in drug molecules, in high yields (up to 97%). The protocol features operational simplicity, avoids the need for precious metal additives/oxidants, and offers broad substrate scope with formal meta- and

  基于弱羧酸盐定向的邻-C-H烷基化和伴随的脱羧过程，开发了一种高效的Ru（II）催化的马来酰亚胺与现成的芳基羧酸进行加氢芳基化反应，制备了3-芳基琥珀酰亚胺，这是药物分子中的常见骨架，高产（高达97％）。该协议具有操作简单，无需贵金属添加剂/氧化剂的特点，并提供了具有正式的间位和对位选择性的广泛底物范围。它代表了Ru（II）催化马来酰亚胺与无偏苯甲酸直接芳基化的第一个例子。
• Chiral Bicyclic Guanidine-Catalyzed Enantioselective Reactions of Anthrones
  作者：Juan Shen、Thanh Truc Nguyen、Yong-Peng Goh、Weiping Ye、Xiao Fu、Junye Xu、Choon-Hong Tan

  DOI：10.1021/ja064636n

  日期：2006.10.1

  catalyst for reactions between anthrones and various dienophiles. The catalyst can tolerate a range of substituents and substitution patterns, making several anthrone derivatives suitable for this reaction. Both Diels-Alder and Michael adducts were obtained in excellent yields, high regioselectivities, and high enantioselectivities. This is the first case of a highly enantioselective base-catalyzed anthrone

  手性双环胍 1 被发现是蒽酮和各种亲二烯体之间反应的极好催化剂。该催化剂可以耐受一系列取代基和取代模式，使几种蒽酮衍生物适用于该反应。Diels-Alder 和 Michael 加合物均以优异的产率、高区域选择性和高对映选择性获得。这是高度对映选择性碱催化蒽酮 Diels-Alder 反应的第一个案例。